S&P Futures
5,637.25 +0.25 (+0.00%) Dow Futures
41,342.00 +7.00 (+0.02%) Nasdaq Futures
19,603.25 +12.00 (+0.06%) Russell 2000 Futures
2,229.20 +1.60 (+0.07%) Crude Oil
77.25 -0.17 (-0.22%) Gold
2,551.90 -3.30 (-0.13%)
Microbot Medical Inc. (MBOT)
After hours:
| Previous Close | 1.0100 |
| Open | 1.0100 |
| Bid | 0.9697 x 100 |
| Ask | 0.9935 x 100 |
| Day's Range | 0.9781 - 1.0100 |
| 52 Week Range | 0.8500 - 2.3500 |
| Volume | |
| Avg. Volume | 2,705,352 |
| Market Cap | 16.148M |
| Beta (5Y Monthly) | 1.68 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7800 |
| Earnings Date | Nov 12, 2024 - Nov 18, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.00 |
ZacksMicrobot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY
Microbot Medical (MBOT) signs a Phase 2 collaboration agreement with Corewell Health to advance remote telesurgery for endovascular procedures using LIBERTY.
GlobeNewswireMicrobot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY? Endovascular Robotic System
The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform The objective of Phase 2 is to develop and demonstrate new telesurgery capabilities by performing simulated interventional procedures between two facilities within the Corewell Health system BRAINTREE, Mass., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY? Endovascular Robotic System, announces that it en
ZacksMicrobot Medical (MBOT) Gets Quality Certification for its System
Microbot Medical (MBOT) secures ISO 13485:2016 certification for its LIBERTY Endovascular Robotic System, a milestone that streamlines European and FDA regulatory compliance for future commercialization.
